Loading...

Smith & Nephew plc

SNNUFPNK
Healthcare
Medical - Devices
$17.30
$0.00(0.00%)

Smith & Nephew plc (SNNUF) Financial Performance & Income Statement Overview

View comprehensive annual and quarterly summaries for Smith & Nephew plc (SNNUF), featuring income statements, balance sheets, and cash flow data.

Revenue Growth
4.70%
4.70%
Operating Income Growth
54.59%
54.59%
Net Income Growth
56.65%
56.65%
Operating Cash Flow Growth
62.34%
62.34%
Operating Margin
13.84%
13.84%
Gross Margin
69.64%
69.64%
Net Profit Margin
7.10%
7.10%
ROE
7.75%
7.75%
ROIC
8.97%
8.97%

Smith & Nephew plc (SNNUF) Income Statement & Financial Overview

Access detailed annual and quarterly income data for Smith & Nephew plc SNNUF financial performance.

MetricQ2 2024Q1 2024Q4 2023Q3 2023
Revenue$1.41B$1.41B$2.86B$1.41B
Cost of Revenue$426.50M$426.50M$908.26M$410.50M
Gross Profit$987.00M$987.00M$1.95B$997.00M
Gross Profit Ratio$0.70$0.70$0.68$0.71
R&D Expenses$68.50M$68.50M$175.76M$109.50M
SG&A Expenses$754.50M$754.50M$1.32B$716.50M
Operating Expenses$823.00M$830.00M$1.50B$930.50M
Total Costs & Expenses$1.25B$1.26B$2.40B$1.34B
Interest Income$0.00$30.50M$16.26M$27.00M
Interest Expense$0.00$0.00$78.23M$0.00
Depreciation & Amortization$96.00M$96.00M$392.16M$69.00M
EBITDA$260.00M$260.00M$560.81M$272.50M
EBITDA Ratio$0.18$0.18$0.30$0.19
Operating Income$164.00M$164.00M$455.15M$203.50M
Operating Income Ratio$0.12$0.12$0.16$0.14
Other Income/Expenses (Net)-$37.50M-$37.50M$15.42M-$35.50M
Income Before Tax$126.50M$126.50M$90.42M$39.50M
Income Before Tax Ratio$0.09$0.09$0.03$0.03
Income Tax Expense$19.50M$19.50M-$12.19M$6.00M
Net Income$107.00M$107.00M$92.45M$45.50M
Net Income Ratio$0.08$0.08$0.03$0.03
EPS$0.12$0.12$0.11$0.05
Diluted EPS$0.12$0.12$0.11$0.05
Weighted Avg Shares Outstanding$873.47M$873.47M$871.87M$875.10M
Weighted Avg Shares Outstanding (Diluted)$873.47M$873.47M$878.44M$872.90M

The company's financials show resilient growth, with revenue advancing from $1.41B in Q3 2023 to $1.41B in Q2 2024. Gross profit remained healthy with margins at 70% in Q2 2024 compared to 71% in Q3 2023. Operating income hit $164.00M last quarter, sustaining a consistent 12% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $260.00M. Net income rose to $107.00M, while earnings per share reached $0.12. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.

Unlock 25+ Years of Financial Data

Get access to extended historical data, advanced metrics, and more with our premium plan

Frequently Asked Questions

;